Background: Urinary tract infection (UTI) is one of the most frequently encountered problems owing to signiÞ cant number of patients needing hospitalization during pregnancy. The incidence of UTI in pregnant women is reported to be high up to 7-8%.
INTRODUCTION
The metabolic syndrome is one of the major public health issues of this century. It is a constellation of physical conditions and metabolic abnormalities, commonly occurring together. If the current trend continues, these conditions will increase the Þ nancial burden in developed and developing countries.
The prevalence of Metabolic Syndrome (MS) and cardiovascular disease (CVD) among South Asians is increasing. This trend is not only seen in South Asians residing on the Indian subcontinent (eg, India, Pakistan, Bangladesh, Nepal), but is also observed in countries with large numbers of South Asian immigrants 1 . It is estimated that 20% -25% of South Asians have developed MS and many more may be prone to it. Urbanization, economic growth, irregular timing of meals and dietary westernization has been suggested as potential culprits implicated in the development of this disorder 2 . In the year 2005, 58 million people died from CVD accounting for 30% of all deaths worldwide; more than half these deaths were in developing countries 3 . If the risk factors associated with CVD go unchecked, then by 2030, when the world population is expected to reach 8.2 billion, 33 percent (24.2 million) of all deaths will be due to CVD 4 .
The aim of the present study was to determine the prevalence of Metabolic Syndrome (MS) using the National Cholesterol Education Program -Adult Treatment Panel III (NCEP-ATP III) criteria 5 the frequency and combination of its deÞ nitive components in patients with Acute Coronary Syndrome (ACS) in Nepal.
METHODS
We performed a hospital-based cross sectional prospective study of consecutive patients admitted in Cardiac Care Unit with diagnosis of acute coronary syndrome at Bir Hospital and Shahid Ganga Lal Heart Center in Kathmandu, Nepal, from 16th July 2005 to 10th August 2006. Total 209 patients with coronary artery disease (Acute coronary syndrome) were enrolled. Patients having coronary by-pass surgery in past, age less than 18 years and other co-morbid diseases were excluded. All patients were informed about the study and a written consent was obtained from them. Acute coronary syndrome (ACS) was diagnosed on the basis of ECG changes and rises in cardiac enzymes and further classiÞ ed into ST elevation Myocardial Infarction (STEMI), Non-ST elevation Myocardial Infarction (NSTEMI) and unstable angina.
Demographic data and presence of known risk factors like hypertension, diabetes mellitus, smoking and dyslipidemia were obtained, along with level of physical activity of at least 30 min daily or 5 days a week. Intake of any antihypertensive drugs, hypoglycemics and lipid lowering drugs were documented. Subjects were assessed for the Þ ve components of metabolic syndrome. Fasting blood samples were drawn for glucose and lipid proÞ le in Þ rst 24 hours after acute coronary insult. Blood pressure was measured by using a standard mercury sphygmomanometer after the subject's pain and anxiety were relieved and the mean value of two measurements taken at least 15 minutes apart was used in the analysis.
Anthropometrics: Height was measured with a stadiometer to the nearest cm; Weight was measured in light clothing without shoes. Waist circumference was measured at narrowest diameter between costal margins and iliac crest or after locating the upper hip bone and top of the right iliac crest, placing the measuring tape in horizontal plane around the abdomen at the level of iliac crest. The body mass index was calculated as the ratio between the weight and the square of the height, according to the international criteria.
Metabolic Syndrome DeÞ nition:
We applied NCEP-ATP III criteria 5 to deÞ ne Metabolic Syndrome (MS). Metabolic syndrome was deÞ ned by the presence of 3 or more out of 5 components: 
RESULTS
The clinical demographic baseline characteristics of the study population are shown in Table 1 
DISCUSSSION
In our study the prevalence of MS in patients with ACS was higher using NCEP-ATP III, as was also observed in other studies 6, 7, 8 . These Þ ndings suggest that MS is very common among the patients with ACS. In this study, MS was detected more in male than that of female which is similar to Progetto CUORE study 9. The prevalence of MS was found more in age group >61 years in this study, as was observed similar in other studies 10, 11 .
Our study, patients with ACS, conÞ rmed the high prevalence of MS in patients with acute STEMI, which was same in study done in Korea
12
. According to the Þ ndings of the PROCAM study, in 40-65-year-old men with DM, there is an 8-fold risk of developing MI within 4 years in those with DM and AH and 19-fold risk in those with DM, AH, and dyslipidemia 13 .
According to the Þ ndings of our study three, four and Þ ve components were detected in 62.5%, 35%, and 2.5% respectively. Literature quotes that more than one-half of patients with IHD and MS have three MS components, more than one-third of such patients have four MS components, and around 10-15% -Þ ve MS components 14, 15, 16 .
In this study MS, regarding prevalence of sex, the results showed increased prevalence of MS in male than female but in many other studies showed predominately in female 17, 18 . Risk factors like smoking, tobacco use, HTN, high TG and high FBG was found signiÞ cantly high in male with MS as compared to female with MS. On the other hand, the men presented a greater frequency of smoking, an important cardiovascular risk factor that is not taken into account in the diagnosis of MS.
Regarding the prevalence of MS risk factors, in this study high FBG (83.3%), high TG (81.7%), HTN (57.5%), high WC in female (76.2%) and low HDL-C in female (69.0%), while in SEPHAR and NATPOL PLUS study AO, low HDL-C, and elevated blood glucose levels were less common 19 . Anderson et al. found that the most common components in patients with IHD were AH, AO, and low HDL-C, while elevated triglyceride concentration and DM were less common 20 ; while in (SMART) study group, elevated blood pressure was the more prevalent risk factor about (61%) 17 , while in Indian study 18 and, in (CADISS) study 21 low HDL was the most prevalent risk factor of MS.
CONCLUSIONS
Our study has identiÞ ed the high prevalence of MS among patients with ACS and suggests that among MS components, hypertension, high FBG, high TG, diabetes mellitus has the strongest relationship with the increased incidence of CAD. Risk factors like smoking, tobacco use, high carbohydrate metabolism and hypertension found in high prevalence in male. 
